NHS to offer thousands of people access to ‘life-extending’ cancer drug
Person holding tablets / medication in their hand / Credit: Ksenia Yakovleva (via Unsplash)
A ‘life-extending’ cancer drug is set to be offered to thousands more patients on the NHS across the country.
As the health service looks to widen the access to treatment nationwide, the prostate cancer drug – known as abiraterone – will be offered to thousands of men whose cancer has not spread in the coming weeks, following the clinical advice to roll it out last year.
Around 2,000 men have been diagnosed with prostate cancer in the last three months, and an additional 7,000 men are expected to be diagnosed each year – all of whom will be eligible for the drug.
The drug works to stop the cancer spreading by starving the disease of the hormones it needs to grow, such as testosterone.
Research has shown that for these earlier stage patients, the survival rate after six years is improved – with trials showing that the proportion of men alive after six years on abiraterone was 86%, compared to 77% on standard treatment (hormone therapy, with or without radiotherapy).
Thousands of men with prostate cancer in England will be offered a life-extending drug on the NHS.
Patients with prostate cancer that has not spread will be able to receive abiraterone on the NHS if it is of clinical benefit.
Read more ⬇️https://t.co/ipUIJk98VI pic.twitter.com/qptiasFhBH— NHS England (@NHSEngland) January 16, 2026
The NHS has worked with campaigners, including Prostate Cancer UK, to secure the rollout of this drug.
In the past five years alone, the NHS in England has also commissioned new innovative targeted prostate cancer therapies – including branded drugs like enzalutamide, darolutamide, relugolix and apalutamide.
“For thousands of men with prostate cancer, this treatment option could be life-changing by helping keep their cancer at bay for several years,” explained Professor Peter Johnson, who is the National Clinical Director for Cancer at NHS England.
“The life-extending treatment available on the NHS within weeks will mean thousands of men can kick-start their year with the news that they will have a better chance of living longer and healthier lives.
Read more:
- NHS becomes first in the world to roll out ‘revolutionary’ blood test to help treat cancer patients
- Five-minute ‘super jab’ to treat 15 different types of cancer rolled-out on NHS
- New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
“The NHS will continue to work hard to offer people the most effective and evidence-based treatments, with several new prostate cancer drugs rolled over the last five years.”
Featured Image – Ksenia Yakovleva (via Unsplash)